Brainstorm Cell Therapeutics Inc.
BCLI· OTC
Filed May 13, 2014 · 10-Q · 43 days after period end · 0001144204-14-029919
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$2.11M | -$1.08M | -$872.00K | -$705.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 13, 2014 · 43 d after period end